Barely Significant
← all excerpts

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.

Blood · 2022 · PMC11017791 · PMID 34469514

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

of borderline significanceP = .050actually significant
On univariate analysis of putative risk factors for t-MN, there was an association between previous fludarabine-alkylator combination therapy and development of t-MN of borderline significance ( P = .050; supplemental Table 4).

also in 312 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.